Design and Efficacy of L-CapA-L-CapC Anticancer-L-RIb-Streptococcus Agalactiae Fusion Protein against COVID-19

Q: How can I download an article?

To download an article from SID, first log in to the site, search for the article title, and click on the 'Download Article' option.

Q: How can I download an ISI article?

To download an ISI article on SID, enter the keyword or article title in the search bar, view the relevant results, click on the desired article, and select the 'Download Article' option.

Q: How can I access the SID database?

To access the SID database, visit SID.ir, create an account, and log in to access scientific resources.

Q: Is downloading articles from SID free?

Some articles on SID are available for free, while others require payment. Details are specified on the article's page.

Babakanrad Elmira; Mohammadian Taher; ESMAEILI DAVOUD; Behzadi Payam

مرکز اطلاعات علمی Scientific Information Database (SID) - Trusted Source for Research and Academic Resources

Journal Paper

Paper Information

Journal: JOURNAL OF MARINE MEDICINE Year:2021 | Volume:3 | Issue:suppl Page(s): 89-95

Download Full-Text

Persian Verion

View:

Download:

Cites:

Information Journal Paper

Title

Design and Efficacy of L-CapA-L-CapC Anticancer-L-RIb-Streptococcus Agalactiae Fusion Protein against COVID-19

Author(s)

Babakanrad Elmira | Mohammadian Taher | ESMAEILI DAVOUD | Behzadi Payam | Issue Writer Certificate

Keywords

SARS-CoV-2

COVID-19

Antibiotic

Bioinformatics

Abstract

Background and Aim: SARS-CoV-2 was identified in late 2019 as a respiratory disease agent called COVID-19. Several drug therapies have been studied to treat COVID-19, none of which have had a definite effect so far. In mild cases of the disease, treatment is careful to reduce the symptoms of the disease, and in severe cases, the patient must be hospitalized to receive different treatments. There are several medications available, many of which are still being evaluated, and there is still no definitive cure for COVID-19 Methods: In this study, an attempt is made to investigate various treatment methods, including the use of LCapA-L-CapC Anticancer-L-Rib-fusion protein in the treatment of COVID-19 in terms of Bioinformatics. In this study, the use of bacterial peptides antiviral drugs is emphasized to introduce appropriate treatment to control SARS-CoV-2 Results: L-CapA-L-CapC Anticancer-L-Rib-fusion protein and Spike virus sequences were extracted using NCBI database. Then, using various software such as SWISS-MODEL and Expasy, the structural model of the protein and its quality were determined. The immunogenicity of L-CapA-L-CapC Anticancer-L-Rib fusion protein was also evaluated. Conclusion: Based on the Bioinformatics results, L-CapA-L-CapC Anticancer-L-Rib fusion protein has a dense and complex structure and in addition to its anti-cancer and anti-viral properties, it can be used in the treatment of COVID-19.

Cites

No record.

References

No record.

Cite

APA: Copy

Babakanrad, Elmira, Mohammadian, Taher, ESMAEILI, DAVOUD, & Behzadi, Payam. (2021). Design and Efficacy of L-CapA-L-CapC Anticancer-L-RIb-Streptococcus Agalactiae Fusion Protein against COVID-19. JOURNAL OF MARINE MEDICINE, 3(suppl ), 89-95. SID. https://sid.ir/paper/1097633/en

Vancouver: Copy

Babakanrad Elmira, Mohammadian Taher, ESMAEILI DAVOUD, Behzadi Payam. Design and Efficacy of L-CapA-L-CapC Anticancer-L-RIb-Streptococcus Agalactiae Fusion Protein against COVID-19. JOURNAL OF MARINE MEDICINE[Internet]. 2021;3(suppl ):89-95. Available from: https://sid.ir/paper/1097633/en

IEEE: Copy

Elmira Babakanrad, Taher Mohammadian, DAVOUD ESMAEILI, and Payam Behzadi, “Design and Efficacy of L-CapA-L-CapC Anticancer-L-RIb-Streptococcus Agalactiae Fusion Protein against COVID-19,” JOURNAL OF MARINE MEDICINE, vol. 3, no. suppl , pp. 89–95, 2021, [Online]. Available: https://sid.ir/paper/1097633/en

Related Journal Papers

No record.

Related Seminar Papers

No record.

Related Plans

No record.

Recommended Workshops